Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of recombinant human Neuregulin-1 in chronic systolic heart failure
ChiCTR-TRC-09000417Phase 2Completed
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Jul 2007
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial in chronic heart failure (CHF) and heart failure (HF) comparing rhNRG-1 plus standard therapy with placebo plus standard therapy (2 arms). Primary endpoint: Hospitalization rate and mortality. Started Jul 2007; status: completed.
02
Drugs
neucardin
03
Conditions
chronic heart failure (CHF)heart failure (HF)
Beyond the preview
Go deeper on ChiCTR-TRC-09000417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000417.